title: [The endoscopic treatment of bronchial fistulas by submucosal injections].
abstract: A total of 21 patients (aged 30-72) with bronchial stump fistulas (307 mm) were treated by a newly developed method of treatment of purulent-destructive pulmonary diseases. This technique represents a gradual narrowing of the bronchial fistula lumen due to infiltrate formation in the submucosal bronchial layer. The volume formation substance biopolymer "DAM+", hydrogenous biopolymer with ions of silver "Argiform" for endoprosthesis of the soft tissues, is injected into the submucosal bronchial layer. It is necessary to make 5-20 fibrobronchoscopies for bronchial fistula healing. No complications occurred as a result of this treatment. The healing of bronchial fistula and bronchial stump epithelization were found in 18 patients.
authors.forename: L N
authors.initials: LN
authors.lastname: Bisenkov
authors.forename: R Sh
authors.initials: RSh
authors.lastname: Bikhodzhin
mesh_terms: D000180:Acrylic Resins / Q000008:administration & dosage*; D000328:Adult; D000368:Aged; D000818:Animals; D001983:Bronchial Fistula / Q000601:surgery / Q000628:therapy*; D001999:Bronchoscopy; D004195:Disease Models, Animal; D004285:Dogs; D005260:Female; D005336:Fiber Optic Technology; D006801:Humans; D007267:Injections; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000601:surgery / Q000628:therapy*; D020545:Respiratory Mucosa; D013908:Thoracotomy; D016896:Treatment Outcome; D000099166:Polyacrylamides
chemical_list: D000180:Acrylic Resins; D000099166:Polyacrylamides